Drugs / VPI-2690B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02251067 Comparator | Sep 2014 → Mar 2017 | diabetic kidney disease | Vascular Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VPI-2690B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02251067 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT02251067 ↗ |